Ironwood Pharma (IRWD) Posts Narrower than Expected Q4 Loss

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $32.15 million versus the consensus estimate of $24.05 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Analog Devices (ADI) Reiterated at Overweight by Cantor Fitzgerald: Beat and Raise Expected
• Evaxion adds brain cancer vaccine program, drops EVX-03